Thoracic Research and Practice
Letter to the Editor

Erlotinib or Radiotherapy in the Treatment of Brain Metastasis from EGRF-Mutant NSCLC?

1.

Department of Radiation Oncology, Kayseri City Education and Research Hospital, Kayseri, Turkey

Thorac Res Pract 2021; 22: 184-185
DOI: 10.5152/TurkThoracJ.2021.20034
Read: 494 Downloads: 189 Published: 01 March 2021

Cite this article as: Benderli Cihan Y. Erlotinib or Radiotherapy in the Treatment of Brain Metastasis from EGRF-Mutant NSCLC? Turk Thorac J 2021; 22(2): 184-5.

Files
EISSN 2979-9139